检索

标题
作者
Efficiency of radiotherapy for cancer of the vermilion border of lower lip in terms of balance between quantitative and qualitative results
Garbuzov M.
Malignant neoplasm of the bronchi and lung: Russian clinical guidelines
Laktionov K., Artamonova E., Borisova T., Breder V., Bychkov I., Vladimirova L., Volkov N., Ergnian S., Zhabina A., Kononets P., Kuz’minov A., Levchenko E., Malikhova O., Marinov D., Miller S., Moiseenko F., Mochal’nikova V., Novikov S., Pikin O., Reutova E., Rodionov E., Sakaeva D., Semenova A., Smolin A., Sotnikov V., Tuzikov S., Turkin I., Tiurin I., Chkhikvadze V., Kolbanov K., Chernichenko A., Fedenko A., Filonenko E., Nevol’skikh A., Ivanov S., Khailova Z., Gevorkian T., Butenko A., Gil’mutdinova I., Gridneva I., Eremushkin M., Zernova M., Kasparov B., Kovlen D., Kondrat’eva K., Konchugova T., Korotkova S., Krutov A., Obukhova O., Ponomarenko G., Semiglazova T., Stepanova A., Tkachenko G., Khulamkhanova M.
PIK3CA mutation: changing the paradigm of HR+ HER2-negative metastatic breast cancer therapy. Review of the Novartis Pharma satellite symposium, held as part of a virtual forum dedicated to the diagnosis and treatment of patients with hormone-dependent HER2-negative advanced breast cancer with a PIK3CA gene mutation. April 23, 2021
Board E.
Synchronous thyroid gland metastases from breast cancer. Case reports
Ognerubov N., Antipova T., Palkina E.
Actual treatment options for locally advanced and metastatic cutaneous squamous cell carcinoma
Ignatova A.
Breast cancer
Zhukova L., Andreeva I., Zavalishina L., Zakiriakhodzhaev A., Koroleva I., Nazarenko A., Paltuev R., Parokonnaia A., Petrovskii A., Portnoi S., Semiglazov V., Semiglazova T., Stenina M., Stepanova A., Trofimova O., Tyulyandin S., Frank G., Frolova M., Shatova I., Nevol’skikh A., Ivanov S., Khailova Z., Gevorkian T.
Novel therapeutic strategies for patients with metastatic triple-negative breast cancer
Ganshina I., Gordeeva O., Manukian M.
Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma
Bolotina L.
Opportunities for metastatic triple negative breast cancer therapy
Ganshina I., Gordeeva O., Manukyan M.
The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience
Kolyadina I., Bulavina I., Petkau V., Strakhova N., Gorbunova V., Kovalenko E., Manziuk L., Artamonova E., Zhukova L., Bolotina L., Gan'shina I., Semiglazova T., Manikhas A., Raevskaia N., Itkin I., Khokhlova S., Filonenko D., Gol'dberg V., Popova N., Ponomarenko D., Shikina V., Vladimirova L., Tikhanovskaia N., Karabina E., Mukhametshina G., Khasanova A., Safina S., Shaidorov M., Orlov A., Kostalanova I., Levchenko N., Osipov M., Karandeeva T., Evstigneeva I., Chernov I., Kolokolov D., Povyshev A., Shatokhina A., Cherniakova E., Shkodenko O., Kuz'mina E.
The post-mastectomy syndrome: the secondary lympedema after the combined treatment of breast cancer (the literature review and own results)
Stepanova A., Merzlyakova A., Khulamhanova M., Trofimova O.
Dermatomyositis and polymyositis in breast cancer patients: a case reports
Ganshina I., Zhukova L., Burnevitch E., Gordeeva O., Kondratieva O.
Eribulin for the treatment of anthracyclineand taxane-resistant breast cancer: a big step forward towards problem solving
Artamonova E.
The treatment of patients with advanced lung cancer associated with EGFR mutation
Bolotina L.
Regorafenib application in patients with metastatic colorectal cancer in actual clinical practice
Sekacheva M., Bagmet N.
Bioequivalence assessment of BCD-022 (trastuzumab, manufactured by JSC BIOCAD, Russia) as compared with Herceptin® (F.Hoffmann-La Roche Ltd., Switzerland), used in combination with paclitaxel in HER2-positive metastatic breast cancer patients: findings of the international, double-blind phase III clinical study
Ignatova E., Burdaeva O., Kopp M., Kotiv B., Udovitsa D., Stroiakovskii D., Alekseev S., Sheveleva L., Khorinko A., Shapovalova I., Moiseenko V., Ivanov R.
Choice of anti-angiogenic agents in second-line treatment in patients with metastatic colon cancer: bevacizumab, aflibercept, ramucirumab (a literature review)
Fedyanin M.
Efficacy and safety of extimia® (empegfilgrastim): results of a double-blind controlled phase iii study in patients with diagnosis «breast cancer» receiving myelosuppressive chemotherapy
Krivorotko P., Burdaeva O., Nechaeva M., Frolova M., Kopp M., Abrosimova A., Ivanov R.
Male breast cancer: review of the literature
Nikolaev K., Semiglazov V., Semiglazov V.
Radiological diagnostics of colorectal cancer liver metastases and immunohistochemical characteristics after drug treatment
Skipenko T., Paltseva E., Sekacheva M., Bedganian A.
Modern treatment possibilities of hormone receptor-positive advanced breast cancer in postmenopausal women
Jackisch C., Llombart-Cussac A.
Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney
Klimenko A., Ivanov S.
The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)
Semiglazov V., Semiglazov V., Paltuev P., Nikolaev K., Dashyan G.
Diagram of differential diagnostics of stages of ovarian cancer
Antoneeva I., Abakumova T., Gening T., Gening S.
Refractory metastatic colorectal cancer: challenges and solutions during the COVID-19 pandemic
Sekacheva M., Fatyanova A., Meretukov D., Zhilenkova A., Rusanov A., Rozhkov A., Guryanova A., Bagmet N.
Antiangiogenic therapy for breast cancer with triple negative phenotype
Ganshina I., Ivanova K., Gordeeva O., Arkhipov A., Zhukova L.
Can any breast skin thickening be staged as T4?
Amosova V., Petrovskii A., Karpova M., Ponedel’nikova N., Frolova M.
The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib
Mazurina N., Artamonova E., Beloyartseva M., Volkova E., Ganshina I., Troshina E., Tjulandin S., Chubenko V.
Reduction of febrile neutropenia by using long-acting granulocyte colony-stimulating factors in patients with solid tumors receiving every-2-week chemotherapy
Kononenko I., Snegovoy A., Grebennikova O., Sel’chuk V., Palchinskaia O.
Virus-associated pharynx tumors in a 16-year-old boy: the description of the clinical case
Gorbunova T., Radtsig E., Merkulov O., Bogomil’skii M., Poliakov V.
The use of regorafenib in colorectal cancer
Sekacheva M., Bagmet N., Guryanova A., Rashi D.
The effectiveness of targeted therapy in the treatment of common forms of ovarian cancer
Saevets V., Vazhenin A., Chernova L., Shimotkina I., Kurchenkova O., Mukhin A., Taratonov A.
Ramucirumab therapy in patients with advanced gastric cancer: discussion of a case series
Orlova R., Zhukova L., Ganshina I., Yukalchuk D., Ponomarenko D., Beliak N., Gordeeva O., Erdniev S., Minasyan A., Dashkova A., Sopiya E., Sholokhova E., Gurochkin A.
Clinico-morphological predictors and treatment outcomes in cervical stump cancer
Usmanova L., Kuznetsov V., Mustafina E., Barinov V., Bokin I., Knyazev R., Akhmedova M.
301 - 334 的 334 信息 << < 1 2 3 4 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##